Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

JAZZ PHARMACEUTICALS PLC (JAZZ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 1 210 persons.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Product1,47799.3%1,60198.9% +8.4%
Royalties and Contract Revenues10.710.7%17.291.1% +61.45%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States1,35591.1%1,46390.4% +8.01%
Europe106.157.1%122.797.6% +15.68%
Other26.911.8%32.452% +20.59%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA542012Chairman & Chief Executive Officer
Daniel N. Swisher Jr., MBA552018President & Chief Operating Officer
Matthew P. Young, MBA492013Chief Financial Officer & Executive Vice President
Karen L. Smith MD, PhD502015Chief Medical Officer & EVP-Research & Development
Paul Treacy572014Senior Vice President-Technical Operations
Paul L. Berns512010Independent Director
Patrick G. Enright, MBA562012Independent Director
Seamus C. Mulligan572012Independent Director
Ken W. O'Keefe, MBA512012Independent Director
Rick E. Winningham, MBA582012Lead Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 59,803,396 58,367,775 97.6% 0 0.0% 97.6%
Shareholders
NameEquities%
Putnam Investment Management LLC 8,272,572 13.8%
Fidelity Management & Research Co. 6,788,088 11.4%
The Vanguard Group, Inc. 4,724,427 7.90%
BlackRock Fund Advisors 2,217,173 3.71%
Senator Investment Group LP 1,398,295 2.34%
Cadian Capital Management LP 1,285,189 2.15%
Renaissance Technologies LLC 1,244,800 2.08%
Westfield Capital Management Co. LP 1,230,572 2.06%
Boston Partners Global Investors, Inc. 1,199,188 2.01%
Waddell & Reed Investment Management Co. 1,067,175 1.78%
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
Connections : Jazz Pharmaceuticals PLC
© 2018 People , Fundamentals and Ownership